Recent developments of interest in cardiovascular medicine
Prescription fish oil icosapent ethyl (Vascepa) was recommended for secondary prevention in diabetes in the American Diabetes Association's updated guidelines. (FiercePharma)
Amarin filed for that indication based on the REDUCE-IT trial, with a decision expected from the FDA by 2020. (Seeking Alpha) The company also announced priority review by Canadian regulators.
For omega-3 fatty acid combination products -- eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) -- at a dose of 1 g/day, the European Medicines Agency cautioned against use for secondary prevention in patients with a prior heart attack, calling it ineffective. "This means that these medicines should no longer be used in this way. However, they can still be used to reduce levels of ... triglycerides."
For preeclampsia, a rapid "red dye on paper" urine test outperformed measured serum and urine markers in a prospective study. (E-Clinical Medicine)
The fastest rising salaries in medicine are in cardiothoracic surgery. (Cardiovascular Business)
GLP-1 receptor agonist drugs that reduce heart risk in type 2 diabetes have seen little uptake by cardiologists. (Journal of the American College of Cardiology)
The first stroke rehabilitation trial for infants is getting underway. (Virginia Tech Daily)
The FDA cleared the CardioFlux Magnetocardiograph device for non-invasive, rapid cardiac imaging and Omron's Complete, a wearable device that combines blood pressure monitoring and EKG. (FDAnews)
The third-generation HeartLight X3 endoscopic laser ablation system was cleared for use in Europe. (Mass Device)
Bystander CPR nearly doubled over the past 18 years in Sweden, researchers reported in Circulation.
In Japan, women are less likely to get bystander CPR than are men. (Mayo Clinic Proceedings)
Fat metabolism in the heart may be tied to heart failure. (Circulation)
Only a handful of states have policies requiring paramedics to take stroke patients straight to a thrombectomy-capable hospital if feasible in time, but just getting all stroke patients to call an ambulance is a bigger hurdle to care. (PEW Trusts Stateline)
A computer model appeared to predict which arrhythmogenic right ventricular cardiomyopathy patients would benefit from primary prevention implantable cardioverter defibrillators better than the standard consensus-based algorithm. (European Heart Journal)
Just how much healthcare spending is racked up due to people sitting too much was detailed in a British study. (Journal of Epidemiology and Community Health)
Read the original article on Medpage Today: Fish Oil Sinks, Vascepa Rises; Preeclampsia Quick Pee Test; Stroke Rehab for Babies